4568:TYO
Daiichi Sankyo Co Ltd
2Â 709,00Â JPÂĄ
arrow_downward
-1,15%(-31,50) 1K
2-okt, 15:30:00 (GMT+9) · JPY
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto4568 tikeri uchun statistika yaratilmoqda...
Ochish
2Â 720Â JPÂĄ
Yuqori
2Â 751Â JPÂĄ
Past
2Â 704Â JPÂĄ
Bozor kapitali
5,05Â trln
Oʻrtacha hajm
6,01Â mln
Hajmi
5,14Â mln
Dividend
2,88%
Choraklik dividendlar
20Â JPÂĄ
P/E koeffitsiyenti
20,52
52 haftalik eng yuqori
4Â 178Â JPÂĄ
52 haftalik eng past
2Â 390Â JPÂĄ
Aksiya boʻyicha daromad
132Â JPÂĄ
Muomaladagi aksiyalar
647,77Â mln
Xodimlar soni
20Â ming
Ochish
2Â 720Â JPÂĄ
Yuqori
2Â 751Â JPÂĄ
Past
2Â 704Â JPÂĄ
Bozor kapitali
5,05Â trln
Oʻrtacha hajm
6,01Â mln
Hajmi
5,14Â mln
Dividend
2,88%
Choraklik dividendlar
20Â JPÂĄ
P/E koeffitsiyenti
20,52
52 haftalik eng yuqori
4Â 178Â JPÂĄ
52 haftalik eng past
2Â 390Â JPÂĄ
Aksiya boʻyicha daromad
132Â JPÂĄ
Muomaladagi aksiyalar
647,77Â mln
Xodimlar soni
20Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Pharmaceutical Executive
·
4 soat oldin
Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics
Yahoo Finance
·
10 soat oldin
Daiichi Sankyo (TSE:4568) Faces Fresh Court Uncertainty After Appeal In Fortis Case
Stock Titan
·
11 soat oldin
AstraZeneca and two partners plan to test a cancer-drug pairing in breast cancer
Reuters
·
11 soat oldin
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination
Profil
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Daiichi Sankyo Co Ltd haqida
CEOHiroyuki Okuzawa
Xodimlar soni20,2Â ming
Asos solingan28-sen, 2005
Bosh ofislarChuo City, Tokio, Yaponiya
Sektor-
Veb-saytdaiichisankyo.co.jp